Biosimilar QC teams run the same problem every week. Complex in-process samples carry proteins, salts, and debris that destroy qPCR sensitivity. You add the sample straight to the reaction and…

What does it mean for EV Research in India? EVOLVE 2026 brought together India's extracellular vesicle research community at ILS, Bhubaneswar this April. Three days of sessions made one thing…

Table of Contents DNA Contamination Risks of residual Host Cell DNA FDA, EMA and CDSCO Requirements Detection Methods DNA HCP ELISA Common Mistakes in DNA Contamination Control 1. DNA Contamination…

Tuberculosis (TB) remains one of the most persistent infectious diseases globally.Despite decades of research and medical advancements, TB continues to impact millions of lives each year. According to the World…

Contents How HCP Testing affects Biosimilar Development? Generic vs Process-Specific HCP Assays Key Selection Criteria for E. Coli HCP ELISA Kits Sensitivity Requirements for Regulatory Compliance Supply Chain Considerations for…

Nearly a century after The Raman Effect, the scientific ecosystem that discovery helped shape has grown dramatically. Biotechnology, diagnostics, biologics, and pharmaceutical innovation now rely on global networks of researchers,…

The International Conference on Autophagy and Cell Biology (ICACB 2026) brought together cell biologists, bioprocess engineers, and translational researchers around a question that keeps surfacing across disciplines: how much of…

The 26th Indian Veterinary Congress convened at ICAR-IVRI Izatnagar on February 12-13, 2026, with a theme that signals where veterinary science is heading: "Progress and Emerging Trends in Animal Health…

India’s veterinary research ecosystem is rapidly evolving, driven by a growing need for advanced diagnostics, vaccines, and innovation in animal health. At institutions like the Indian Veterinary Research Institute (IVRI) — one…

Choosing an ELISA kit is often treated as a procurement task.In reality, it is a scientific decision with long-term consequences. In bioanalysis, diagnostics, and biosimilar development, the ELISA kit you…

India’s Union Budget 2026–27 introduced a defining initiative for the life sciences sector: Biopharma SHAKTI. More than a funding announcement, Biopharma SHAKTI represents a long-term structural strategy — one aimed at strengthening India’s…

Every mature biotech ecosystem follows a familiar arc. It begins with import dependence — on reagents, assays, instruments, and expertise developed elsewhere. Over time, as scientific capability deepens and regulatory expectations evolve,…